Celiac Disease Study by Alba Therapeutics:
A Two-Part Study, Randomized, Double-Blind, Placebo Controlled Study to a) Validate a Patient Reported Outcome for Active Celiac Disease and b) to Evaluate the Efficacy and Safety of investigational product (IP) for the Treatment of Celiac Disease.